- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Onesource Specialty Pharma Limited — Updates, 14-01-2026: General Updates
14-01-2026 | 04:50 pm
14-01-2026 | 04:50 pm
OneSource Pharma amalgamated wholly-owned subsidiaries Stelis Pte. (USD 7.86 million turnover) and Onesource Specialty Pte. (USD 34.09 million turnover). This streamlines corporate structure, boosting operational efficiency and cutting costs. No impact on consolidated financials or shareholding.
No comments yet. Be the first to comment!